Chinese drug makers showcase positive cancer trial results at European conference
Hansoh Pharmaceutical and Akeso presented new data for cancer treatments at the European Society for Medical Oncology Congress in Madrid from October 23 to 27.
Chinese firms dominate late-breaking abstracts
Analysts noted that Chinese research accounted for 29 of the 96 late-breaking abstracts presented at the event. Five of the 12 studies chosen for the presidential symposium also came from Chinese companies. These presentations highlighted the growing international influence of the nation's biotech sector.
Antibody-drug conjugates show strong data
Domestic innovative drugs, particularly antibody-drug conjugates, delivered impressive results across multiple tumour types during the conference. Some early-stage data further demonstrated the country's innovation capabilities in this field. An array of drug makers used these outcomes to underscore their expanding global reach.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.